Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition

被引:2
|
作者
Tortolini, Cristina [1 ]
Gigli, Valeria [1 ]
Rizzo, Flavio [1 ]
Lenzi, Andrea [1 ]
Bizzarri, Mariano [1 ]
Angeloni, Antonio [1 ]
Antiochia, Riccarda [2 ]
机构
[1] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Chem & Drug Technol, Piazzale Aldo Moro 5, I-00185 Rome, Italy
关键词
myo-inositol; D-chiro-inositol; biosensor; stereoselective recognition; voltammetric detection; MWCNTs; ENANTIOMERIC SEPARATION; ENANTIOSELECTIVE RECOGNITION; CAPILLARY-ELECTROPHORESIS; ELECTROCHEMICAL SENSOR; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; DRUGS; MEDIATORS; DISEASE; BINDING;
D O I
10.3390/s23229211
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This paper describes the development of a simple voltammetric biosensor for the stereoselective discrimination of myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) by means of bovine serum albumin (BSA) adsorption onto a multi-walled carbon nanotube (MWCNT) graphite screen-printed electrode (MWCNT-GSPE), previously functionalized by the electropolymerization of methylene blue (MB). After a morphological characterization, the enantioselective biosensor platform was electrochemically characterized after each modification step by differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy (EIS). The results show that the binding affinity between myo-Ins and BSA was higher than that between D-chiro-Ins and BSA, confirming the different interactions exhibited by the novel BSA/MB/MWCNT/GSPE platform towards the two diastereoisomers. The biosensor showed a linear response towards both stereoisomers in the range of 2-100 mu M, with LODs of 0.5 and 1 mu M for myo-Ins and D-chiro-Ins, respectively. Moreover, a stereoselectivity coefficient alpha of 1.6 was found, with association constants of 0.90 and 0.79, for the two stereoisomers, respectively. Lastly, the proposed biosensor allowed for the determination of the stereoisomeric composition of myo-/D-chiro-Ins mixtures in commercial pharmaceutical preparations, and thus, it is expected to be successfully applied in the chiral analysis of pharmaceuticals and illicit drugs of forensic interest.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] From Myo-inositol to D-chiro-inositol molecular pathways
    Kiani, A. K.
    Paolacci, S.
    Calogero, A. E.
    Cannarella, R.
    Di Renzo, G. C.
    Gerli, S.
    Della Morte, C.
    Busetto, G. M.
    De Berardinis, E.
    Del Giudice, F.
    Stuppia, L.
    Facchinetti, F.
    Dinicola, S.
    Bertelli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2390 - 2402
  • [2] Myo-inositol/D-chiro-inositol metabolism in HIV lipodystrophy syndrome
    Placek, J
    Palmer, M
    Currier, J
    Vasquez, G
    ANTIVIRAL THERAPY, 2004, 9 (06) : L54 - L54
  • [3] myo-inositol oxygenase:: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol
    Arner, RJ
    Prabhu, KS
    Thompson, JT
    Hildenbrandt, GR
    Liken, AD
    Reddy, CC
    BIOCHEMICAL JOURNAL, 2001, 360 : 313 - 320
  • [4] Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
    Bizzarri, Mariano
    Monti, Noemi
    Piombarolo, Aurora
    Angeloni, Antonio
    Verna, Roberto
    NUTRIENTS, 2023, 15 (08)
  • [5] The Rationale of the Myo-Inositol and D-Chiro-Inositol Combined Treatment for Polycystic Ovary Syndrome
    Dinicola, Simona
    Chiu, Tony T. Y.
    Unfer, Vittorio
    Carlomagno, Gianfranco
    Bizzarri, Mariano
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1079 - 1092
  • [6] Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
    Lete, Inaki
    Martinez, Ainara
    Lasaga, Irene
    Centurion, Eva
    Vesga, Amaia
    GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [7] Effects of D-chiro-inositol and myo-inositol on the cataractogenesis of the xylose-induced rat lenses
    Lee, WK
    Kim, H
    FASEB JOURNAL, 2002, 16 (04): : A640 - A640
  • [8] Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome
    Unfer, Vittorio
    Porcaro, Giuseppina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 623 - 631
  • [9] The Combined therapy with myo-inositol and D-Chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
    Nordio, M.
    Proietti, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (05) : 575 - 581
  • [10] Management of polycystic ovary syndrome among Indian women using myo-inositol and D-chiro-inositol
    Vyas, Lila
    Raiturker, Anagha Pai
    Sud, Shilpi
    Goyyal, Poonam
    Abhyankarv, Mahesh
    Ankar, Santosh Rev
    Silki, Silki
    BIOINFORMATION, 2022, 18 (02) : 103 - 110